Workflow
国药股份
icon
Search documents
国药股份(600511.SH):2025年中报净利润为9.49亿元、同比较去年同期下降5.19%
Xin Lang Cai Jing· 2025-08-21 01:29
Financial Performance - The company reported total revenue of 25.634 billion, an increase of 877 million compared to the same period last year, marking a year-on-year growth of 3.54% [1] - The net profit attributable to shareholders was 949 million, a decrease of 51.963 million from the same period last year, reflecting a year-on-year decline of 5.19% [1] - The net cash inflow from operating activities was -1.510 billion, a decrease of 444 million compared to the same period last year [1] Key Financial Ratios - The latest debt-to-asset ratio is 44.41%, a decrease of 0.14 percentage points from the previous quarter and a decrease of 2.12 percentage points from the same period last year [3] - The latest gross profit margin is 6.14%, down 0.18 percentage points from the previous quarter and down 0.94 percentage points from the same period last year [3] - The latest return on equity (ROE) is 5.43%, a decrease of 0.78 percentage points from the same period last year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share (EPS) is 1.26, a decrease of 0.07 from the same period last year, reflecting a year-on-year decline of 5.20% [3] - The latest total asset turnover ratio is 0.74 times, a decrease of 0.01 times from the same period last year [3] - The latest inventory turnover ratio is 4.69 times, a decrease of 0.47 times from the same period last year, reflecting a year-on-year decline of 9.04% [3] Shareholder Information - The number of shareholders is 47,400, with the top ten shareholders holding a total of 522 million shares, accounting for 69.25% of the total share capital [3] - The largest shareholder is China National Pharmaceutical Group Co., Ltd., holding 54.7% of the shares [3]
险资二季度动向:截至8月21日 共现身131只个股前十大流通股东
Di Yi Cai Jing· 2025-08-21 00:38
数据统计显示,8月21日,险资现身21只个股前十大流通股东,合计持股3.43亿股,合计持股市值达 66.53亿元。平高电气、许继电气、白云机场持股数量居前,险资分别持有1.09亿股、0.59亿股、0.40亿 股。从险资持股市值来看,平高电气、许继电气、国药股份排名居前,持股市值分别为16.70亿元、 12.81亿元、11.52亿元。 截至8月21日,险资二季度共现身131只个股前十大流通股东,合计持股97.77亿股,合计持股市值达 790.09亿元。其中,63只个股持股数量超千万,中国联通、中国电信、南玻A持股数量居前,险资分别 持有31.90亿股、10.97亿股、6.50亿股。从险资持股行业分布来看,主要集中在材料Ⅱ、资本货物、技 术硬件与设备,分别有29只、20只、14只。 (文章来源:第一财经) ...
社保基金二季度动向:截至8月21日 共现身131只个股前十大流通股东
Di Yi Cai Jing· 2025-08-21 00:38
Group 1 - The social security fund appeared as a major shareholder in 26 stocks as of August 21, holding a total of 312 million shares valued at 5.606 billion yuan [1] - The top three stocks by the number of shares held by the social security fund are Longbai Group, Shengnong Development, and China Xidian, with holdings of 35 million shares, 32 million shares, and 31 million shares respectively [1] - In terms of market value, the leading stocks held by the social security fund are China National Pharmaceutical, Longbai Group, and Naxin Micro, with values of 651 million yuan, 563 million yuan, and 518 million yuan respectively [1] Group 2 - As of August 21, the social security fund was among the top ten shareholders in 131 stocks in the second quarter, with a total of 2.036 billion shares valued at 33.42 billion yuan [1] - There are 54 stocks where the social security fund holds over 10 million shares, with Changshu Bank, Nanjing Steel, and Huafa Holdings having the highest number of shares at 278 million, 103 million, and 90 million respectively [1] - The industry distribution of the social security fund's holdings is primarily concentrated in chemicals, pharmaceuticals, electronic equipment, instruments, and components, with 21, 13, and 12 stocks in these sectors respectively [1]
养老金二季度动向:截至8月21日,共现身38只个股前十大流通股东
Xin Lang Cai Jing· 2025-08-21 00:35
据Wind数据统计显示,8月21日,养老金现身8只个股前十大流通股东,合计持股5349.14万股,合计持 股市值达14.15亿元。国药股份、华峰铝业、海兴电力持股数量居前,养老金分别持有0.18亿股、0.10亿 股、0.07亿股。从养老金持股市值来看,国药股份、盐津铺子、海兴电力排名居前,持股市值分别为 5.20亿元、3.17亿元、1.73亿元。截至8月21日,养老金二季度共现身38只个股前十大流通股东,合计持 股3.23亿股,合计持股市值达79.75亿元。其中,7只个股持股数量超千万,海油发展、宏发股份、深圳 机场持股数量居前,养老金分别持有0.52亿股、0.28亿股、0.24亿股。从养老金持股行业分布来看,主 要集中在化工、制药、机械,分别有4只、3只、3只。 ...
社保基金、养老金,最新动向曝光
Group 1 - The core viewpoint of the articles highlights the increasing presence of national social security funds and basic pension insurance funds in the top ten shareholders of listed companies as of August 20, 2025, with over 40 social security fund combinations and more than 10 basic pension fund combinations being reported [1][3][10] - The national social security fund combinations have a broad investment scope, appearing in the top ten shareholders of over 120 A-share listed companies by the end of the second quarter [3][10] - The top ten stocks held by national social security fund combinations include companies like Pengding Holdings and Wanhua Chemical, both of which have a market value exceeding 10 billion yuan [7][8] Group 2 - The basic pension insurance fund combinations have invested in over 30 stocks, with notable interest in companies such as Chunfeng Power and Lanxiao Technology, where the holdings exceed 10 billion yuan [9][10] - Chunfeng Power has received significant attention from multiple basic pension fund combinations, with one fund holding over 190 million shares valued at approximately 400 million yuan [10] - The total market value held by national social security fund combinations and basic pension fund combinations in A-share companies exceeded 40 billion yuan by the end of the second quarter [10]
国药集团药业股份有限公司2025年半年度报告摘要
Group 1 - The company held its eighth board meeting on August 19, 2025, where all seven directors attended, including four independent directors [3][4] - The board approved the 2025 semi-annual report and the special report on the use of raised funds, with unanimous votes [4][6] - The company has implemented a management system for raised funds, ensuring compliance with relevant regulations [17][28] Group 2 - The company raised a total of RMB 1,029,999,754.80, with a net amount received of RMB 1,018,217,601.99 after deducting issuance costs [12][14] - As of June 30, 2025, the company used RMB 8.5 billion of idle raised funds to temporarily supplement working capital [21] - The company has completed the "Information System Construction Project" and has no remaining expenditures related to this project [15][21] Group 3 - The company announced the resignation of Vice President Ye Tong due to retirement, effective immediately upon delivery of the resignation letter [30][31] - The company confirmed that Ye Tong's departure will not affect its normal operations [31]
国药股份:公司高级管理人员离任
Zheng Quan Ri Bao Wang· 2025-08-20 14:12
Core Viewpoint - The announcement indicates that the Vice President of China National Pharmaceutical Group Corporation (国药股份) has resigned due to retirement, and will no longer hold any position within the company [1] Group 1 - The resignation was formally submitted on August 19, 2025 [1] - The individual resigning is Ms. Ye Tong, who served as the Vice President [1] - Following her resignation, she will not hold any roles within the company [1]
国药股份:第八届董事会第二十八次会议决议公告
Zheng Quan Ri Bao· 2025-08-20 13:46
(文章来源:证券日报) 证券日报网讯 8月20日晚间,国药股份发布公告称,公司第八届董事会第二十八次会议审议通过了《国 药股份2025年半年度报告全文及摘要的议案》等多项议案。 ...
国药股份:2025年半年度归属于上市公司股东的净利润为948547379.33元
(编辑 何成浩) 证券日报网讯 8月20日晚间,国药股份发布公告称,2025年半年度公司实现营业收入25,633,950, 652.46元,同比增长3.54%;归属于上市公司股东的净利润为948,547,379.33元,同比下降5.19%。 ...
国药控股(01099):国药股份(600511.SH)上半年归母净利9.49亿元 同比下降5.19%
智通财经网· 2025-08-20 11:33
Group 1 - The core viewpoint of the article is that China National Pharmaceutical Group (国药控股) reported its subsidiary China National Pharmaceutical Co., Ltd. (国药股份) financial performance for the first half of 2025, showing a slight increase in revenue but a decline in net profit [1] - The operating revenue for the first half of 2025 was approximately 25.634 billion yuan, representing a year-on-year growth of 3.54% [1] - The net profit attributable to shareholders of the listed company was approximately 949 million yuan, reflecting a year-on-year decrease of 5.19% [1] - The basic earnings per share were reported at 1.2572 yuan [1]